Coronary flow reserve and myocardial performance index in newly diagnosed diabetic patients

Gülhan Yüksel Kalkan1, Mustafa Gür, Durmuş Yıldıray Şahin

  • 1Department of Cardiology, Adana Numune Training and Research Hospital, Adana, Turkey.

Insights

Newly diagnosed diabetes mellitus patients show reduced coronary flow reserve (CFR) linked to impaired heart function. Myocardial performance index (MPI) is a key indicator of this dysfunction in diabetic individuals.

Area of Science:

  • Cardiology
  • Diabetology
  • Medical Imaging

Background:

  • Diabetes mellitus (DM) significantly increases the risk of left ventricular (LV) dysfunction.
  • Reduced coronary flow reserve (CFR) is observed in diabetic patients even without coronary artery stenosis.
  • Investigating LV systolic and diastolic functions in relation to CFR is crucial for early detection in asymptomatic diabetics.

Purpose of the Study:

  • To explore the association between LV myocardial diastolic and systolic functions and CFR.
  • To evaluate cardiac function parameters in newly diagnosed diabetic patients.
  • To determine the role of myocardial performance index (MPI) in assessing CFR in this population.

Main Methods:

  • Transthoracic echocardiography was performed on 88 newly diagnosed DM patients and 40 controls.
  • Myocardial performance index (MPI) was measured using pulsed-wave Doppler.
  • Coronary flow reserve (CFR) was calculated by comparing hyperemic to resting coronary diastolic peak velocities.

Main Results:

  • Diabetic patients exhibited prolonged mitral E-wave deceleration time and higher MPI compared to controls.
  • Mean CFR was significantly lower in diabetic patients.
  • MPI strongly correlated with CFR, LV ejection fraction, E/A ratio, and glycosylated hemoglobin (HbA1c).

Conclusions:

  • Myocardial performance index (MPI) is independently associated with CFR in patients with newly diagnosed diabetes mellitus.
  • Decreased CFR may contribute to LV systolic and diastolic dysfunction in asymptomatic diabetic patients.
  • MPI serves as a valuable marker for assessing cardiac health in diabetic individuals.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...